139 related articles for article (PubMed ID: 10997726)
1. RTI-76, an isothiocyanate derivative of a phenyltropane cocaine analog, as a tool for irreversibly inactivating dopamine transporter function in vitro.
Wang LC; Berfield JL; Kuhar MJ; Carroll FI; Reith ME
Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):238-47. PubMed ID: 10997726
[TBL] [Abstract][Full Text] [Related]
2. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride].
Fleckenstein AE; Pögün S; Carroll FI; Kuhar MJ
J Pharmacol Exp Ther; 1996 Oct; 279(1):200-6. PubMed ID: 8858994
[TBL] [Abstract][Full Text] [Related]
3. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
5. Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.
Rothman RB; Silverthorn ML; Baumann MH; Goodman CB; Cadet JL; Matecka D; Rice KC; Carroll FI; Wang JB; Uhl GR
J Pharmacol Exp Ther; 1995 Jul; 274(1):385-95. PubMed ID: 7616423
[TBL] [Abstract][Full Text] [Related]
6. Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76.
Kimmel HL; Carroll FI; Kuhar MJ
Neuropharmacology; 2000 Feb; 39(4):578-85. PubMed ID: 10728879
[TBL] [Abstract][Full Text] [Related]
7. Modeling of the interaction of Na+ and K+ with the binding of dopamine and [3H]WIN 35,428 to the human dopamine transporter.
Li LB; Reith ME
J Neurochem; 1999 Mar; 72(3):1095-109. PubMed ID: 10037481
[TBL] [Abstract][Full Text] [Related]
8. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
[TBL] [Abstract][Full Text] [Related]
9. Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121.
Staley JK; Boja JW; Carroll FI; Seltzman HH; Wyrick CD; Lewin AH; Abraham P; Mash DC
Synapse; 1995 Dec; 21(4):364-72. PubMed ID: 8869167
[TBL] [Abstract][Full Text] [Related]
10. Differential binding of tropane-based photoaffinity ligands on the dopamine transporter.
Vaughan RA; Agoston GE; Lever JR; Newman AH
J Neurosci; 1999 Jan; 19(2):630-6. PubMed ID: 9880583
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, dopamine transporter affinity, dopamine uptake inhibition, and locomotor stimulant activity of 2-substituted 3 beta-phenyltropane derivatives.
Xu L; Kelkar SV; Lomenzo SA; Izenwasser S; Katz JL; Kline RH; Trudell ML
J Med Chem; 1997 Mar; 40(6):858-63. PubMed ID: 9083474
[TBL] [Abstract][Full Text] [Related]
12. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
Boja JW; Rahman MA; Philip A; Lewin AH; Carroll FI; Kuhar MJ
Mol Pharmacol; 1991 Mar; 39(3):339-45. PubMed ID: 1826041
[TBL] [Abstract][Full Text] [Related]
13. Binding domains for blockers and substrates on the cloned human dopamine transporter studied by protection against N-ethylmaleimide-induced reduction of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)[3H]tropane ([3H]WIN 35,428) binding.
Reith ME; Xu C; Coffey LL
Biochem Pharmacol; 1996 Nov; 52(9):1435-46. PubMed ID: 8937455
[TBL] [Abstract][Full Text] [Related]
14. Novel tropane-based irreversible ligands for the dopamine transporter.
Zou MF; Kopajtic T; Katz JL; Wirtz S; Justice JB; Newman AH
J Med Chem; 2001 Dec; 44(25):4453-61. PubMed ID: 11728190
[TBL] [Abstract][Full Text] [Related]
15. Prolonged dopamine and serotonin transporter inhibition after exposure to tropanes.
Bennett BA; Hollingsworth CK; Martin RS; Childers SR; Ehrenkaufer RE; Porrino LJ; Davies HM
Neuropharmacology; 1998; 37(1):123-30. PubMed ID: 9680265
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structure, dopamine transporter affinity, and dopamine uptake inhibition of 6-alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane derivatives.
Lomenzo SA; Izenwasser S; Katz JL; Terry PD; Zhu N; Klein CL; Trudell ML
J Med Chem; 1997 Dec; 40(26):4406-14. PubMed ID: 9435910
[TBL] [Abstract][Full Text] [Related]
17. Modeling of the pH dependence of the binding of WIN 35,428 to the dopamine transporter in rat striatal membranes: is the bioactive form positively charged or neutral?
Xu C; Reith ME
J Pharmacol Exp Ther; 1996 Sep; 278(3):1340-8. PubMed ID: 8819521
[TBL] [Abstract][Full Text] [Related]
18. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
[TBL] [Abstract][Full Text] [Related]
19. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.
Agoston GE; Wu JH; Izenwasser S; George C; Katz J; Kline RH; Newman AH
J Med Chem; 1997 Dec; 40(26):4329-39. PubMed ID: 9435902
[TBL] [Abstract][Full Text] [Related]
20. Displacement of RTI-55 from the dopamine transporter by cocaine.
Gatley SJ; Volkow ND; Chen R; Fowler JS; Carroll FI; Kuhar MJ
Eur J Pharmacol; 1996 Jan; 296(2):145-51. PubMed ID: 8838450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
